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Abstract
Background: Herpes simplex virus (HSV) is the most common identified cause of focal encephalitis worldwide.
However, postoperative HSV encephalitis (HSVE) is a rare complication of neurosurgical procedures and a significant
clinical challenge
Method: We describe 3 cases of postoperative HSVE and review all published reports. A total of 23 cases were identified.
Discussion: Clinical heterogeneity represents a diagnostic challenge in the postoperative setting. Cerebral magnetic
resonance imaging showed typical findings in a minority of patients only, whereas HSV-specific polymerase chain
reaction on the cerebrospinal fluid proved to be a valuable test. The postoperative viral pathophysiology remains a
subject of debate. The rate of adverse outcome is high and early antiviral treatment seems to be a strong predictor
of clinical outcome.
Conclusion: We recommend early empirical treatment for any patient presenting with post-neurosurgical lymphocytic
meningo-encephalitis, and prophylactic antiviral treatment for patients with a history of previous HSVE who will undergo
a neurosurgical procedure.
Keywords: Herpes simplex virus, Meningitis, Encephalitis, Neurosurgery, Complication, Postoperative
Abbreviations: CNS, Central nervous system; CSF, Cerebrospinal fluid; HSV, Herpes simplex virus; HSVE, Herpes simplex
virus encephalitis; IV, Intravenous; PCR, Polymerase chain reaction; POD, Postoperative day.
Key points
We report 3 cases of postoperative herpes simplex enceph-
alitis and review the existing literature. The importance of
early empiric treatment is highlighted. We recommend
prophylactic treatment before neurosurgery for patients
with a history of previous herpetic encephalitis.
Background
Herpes simplex virus (HSV) is the most common identi-
fied cause of acute and focal sporadic encephalitis in the
Western world with an incidence of 1–3 cases per million
inhabitants each year [1]. Without treatment, mortality
can be as high as 70 % as opposed to 30 % with adequate
treatment and neurological sequelae are frequent, even in
treated cases [1]. It has traditionally been recognized that
HSV-1 is associated with encephalitis, whereas HSV-2 is a
predominant cause of aseptic meningitis. However, a sig-
nificant overlap exists and more than 15 % of patients with
HSV-2 central nervous system (CNS) infection present
with encephalitis rather than meningitis [2]. HSV infection
is characterized by peripheral nervous system latency and
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potential reactivation from quiescent episome triggered by
various stimuli [3]. It is estimated that approximately two-
thirds of HSV encephalitis (HSVE) cases occur because of
reactivation, rather than primary infection [4]. HSVE trig-
gered by neurosurgical procedures per se is a rare occur-
rence and deserves special attention. Initial management
is challenging because early therapy is critical in a setting
where serious intracranial infections are caused almost ex-
clusively by iatrogenic bacterial species. In this article, we
present 3 post-neurosurgical HSVE cases diagnosed
and managed at our center, review the literature on




A 24-year-old man underwent right lateral sub-occipital
craniotomy for resection of an epidermoid cyst of the right
cerebellopontine angle. Evolution was uneventful and he
was discharged at postoperative day (POD) 4 under dexa-
methasone (4 mg two times per day) for one week. On
POD 8, he experienced fever associated with worsening
headache. He sought medical attention and was treated
with intravenous (IV) ceftriaxone, flucloxacillin and metro-
nidazole (POD 9). The following day, he developed agitated
behavior and a decreased level of consciousness. Magnetic
resonance imaging (MRI) showed leptomeningeal enhance-
ment in the supra and infratentorial regions without evi-
dence of abscess or empyema (Fig. 1). A lumbar puncture
showed lymphocytic meningitis: 1517 M/l leucocytes,
95 % lympho-monocytes, 1 M/l erythrocytes, 0.94 g/l
protein, 2.7 mmol/l glucose and 3.2 mmol/l lactate. He
was intubated during 24 h and treatment was modified
to IV meropenem, vancomycin and acyclovir 10 mg/kg
three times daily (POD 11). Cerebrospinal fluid (CSF) cul-
tures remained negative, while the specific polymerase
chain reaction (PCR) was positive for HSV-1. Antibiotics
were stopped on POD 15 and the patient improved pro-
gressively under acyclovir. Subarachnoid hemorrhage with
hydrocephaly developed on POD 24. An arteriography
showed a ruptured, right anterior inferior cerebellar artery
pseudo-aneurysm of traumatic origin attributed to the
surgery. Acyclovir treatment was stopped after 21 days.
After a 2-month stay, he was discharged with improving
right peripheral facial palsy secondary to the hemorrhagic
complication and presented no clinical sequelae of the
HSV-1 infection.
Case 2
A 53-year-old man underwent an uncomplicated right
pterional craniotomy with total resection of a World
Health Organization grade I craniopharyngioma. He was
discharged on POD 9 under dexamethasone (3 mg three
times daily) with subsequent dose tapering. On POD 18,
the patient experienced fever and was drowsier than usual.
A computed tomography scan showed a right frontal sub-
dural collection; an empyema could not be excluded
(Fig. 2a). However, an MRI showed no sign of empyema
but instead leptomeningeal enhancement and lesions
compatible with acute ischemic changes in the right cor-
ona radiata and centrum semiovale (Fig. 2b). CSF analysis
showed lymphocytic meningitis with 188 M/l leucocytes,
92 % lympho-monocytes, 26 M/l erythrocytes, 1.25 g/l
protein, 1.6 mmol/l glucose, and 4.2 mmol/l lactate. No
bacteria were detected on direct examination of the fluid.
He was started on IV meropenem, vancomycin, and
acyclovir 15 mg/kg three times daily (POD 19). The next
day, revision surgery was performed with cranial flap
removal. Operative status was normal and showed no sign
of empyema. Surgical samples showed no bacteria on dir-
ect examination and cultures remained negative. Broad-
range PCR for bacteria on surgical samples was negative
and vancomycin and meropenem were stopped on POD
22 and 27, respectively. HSV-2 DNA PCR came back posi-
tive on the CSF. IV acyclovir was continued for a total
duration of 21 days and he improved rapidly. Neurological
status at discharge was comparable to baseline.
Case 3
A young girl suffered from HSV-1 encephalitis at the age of
11 months. By that time, she had predominant involvement
of her right temporal lobe in the form of a multiple area of
focal encephalomalacia (Fig. 3a) and exhibited clinically
Fig. 1 Coronal FLAIR MRI sequence illustrates a diffuse leptomeningeal
enhancement (arrows) after surgery of an epidermoid cyst of the right
cerebellopontine angle
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minimal left-sided weakness. Over the years, her epilepsy
had worsened and became progressively intractable. At
12 years of age, epileptic surgery was considered. She
underwent a right temporal lobectomy and amygdalohip-
pocampectomy and was discharged at POD 7 without
steroids. At POD 11, she presented to the emergency
department for headache associated with fever. A worsen-
ing level of consciousness at POD 14 prompted a cerebral
MRI that demonstrated abnormal signal intensity with
vasogenic edema distant from the resected area and
compatible with an inflammatory process (Fig. 3b). CSF
analysis revealed mild pleocytosis with 91 M/l leucocytes,
Fig. 2 Post-surgical CT visualization of a right frontal heterogeneous collection (2a, left). MRI showed no empyema but ischemic lesions of the
right deep frontal white matter (2b, right)
Fig. 3 Sequels of HSVE at the level of the temporal lobe and right hippocampus (3a, upper left, arrows and asterisk). Post-surgical MRI shows areas of
suspected encephalitis with high signal on T2 in the right frontal, parietal and temporal lobes at 3 weeks (3b, upper right), associated with hemorrhagic
transformation and mass effect one month later (3c, lower left). Follow-up MRI at 45 days showed large sequelae of the temporal lobe (3d, lower right)
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96 % lympho-monocytes, 837 M/l erythrocytes, 2.05 g/l
protein, 1.9 mmol/l glucose and 2.7 mmol/l lactate. Empiric
IV ceftriaxone and vancomycin were first initiated for pre-
sumed superficial wound infection and contiguous bacterial
cerebritis. Considering possible HSV relapse, acyclovir
20 mg/kg three times daily was started 24 h later. Positive
HSV-1 PCR on the CSF confirmed the diagnosis. Four days
after the initiation of acyclovir (POD 18) and after a transi-
ent improvement, she complained of severe headache and
became confused. An urgent MRI revealed a malignant
edema with a significant mass effect (Fig. 3c) prompting a
rapid decompressive right frontoparietotemporal craniect-
omy (Fig. 3d). Thereafter, evolution was fortunately favor-
able. Her neurological status returned to baseline except for
a worsening of the preexisting left hemiplegia. Acyclovir




We identified cases in PubMed without any exclusion
criterion, using the key words “herpes”, “herpetic”, “men-
ingitis” or “encephalitis” and one of the following terms:
“postoperative”, “surgery”, “neurosurgery” or “craniot-
omy”. All identified articles and the cited references
were searched to identify any other cases.
Results
A total of 23 cases of HSVE were identified (Table 1). There
seems to be no age predisposition as postoperative HSVE
can manifest in the pediatric population [5–10], and in
adults [6, 11–26]. A minority of patients only had a previ-
ous history of HSVE [5, 7, 8, 10, 15, 16, 25]. Most adult
patients had uncomplicated neurosurgery for various types
of brain tumor. Other surgical indications were: Chiari
malformation type 1 [13], refractory epilepsy secondary to
previous or presumed HSVE [15, 16, 25, 26] and refractory
trigeminal neuralgia [21]. Regarding pediatric cases, neuro-
surgery was performed for refractory epilepsy secondary to
a previous HSVE in 4 patients [5, 7, 8, 10], and CNS tumor
for 2 [6, 9]. Time-to-symptom onset was highly variable
and varied from only a few hours [21] to 3 weeks [18] post-




The vast majority of CNS infections complicating neuro-
surgery are of bacterial origin and postoperative HSVE
remains an exceptional situation, yet not one to miss. Re-
ported cases show great clinical heterogeneity regarding
age, type of surgery, and symptom delay (Tables 1 & 2).
This non-specific clinical picture can make early diagnosis
difficult and delay appropriate treatment. This is all the
more important since postoperative HSVE severity seems
comparable to sporadic cases with unfavorable outcome in
more than half of patients (Table 3).
Clinical aspects
Several aspects of the above-reported cases are worth con-
sidering. First, the latency observed between the surgery
and the first symptoms was longer in patient 2 (POD 18)
than most of the previous cases described and only 1
other case showed a longer latency (POD >21) [18]. This
illustrates that there is no definite time frame and the
physician must consider HSVE as a potential diagnosis,
even several weeks after initial surgery. Second, only 3
other cases of postoperative HSV-2 CNS infection have
been described [13, 19, 26] (Table 2), 2 of which [19, 26]
presented with encephalitis. This emphasizes that benign
aseptic meningitis is not the sole manifestation of HSV-2
CNS infection. This is supported by a recent study show-
ing that more than 15 % of HSV-2 sporadic CNS infection
can present with encephalitis, rather than meningitis [2].
Of note, similar to the case reports of Vik-Mo et al. [26]
and Perry et al. [19], patient 2 had no prior history of
labial or genital herpetic infection. However, such a his-
tory is found only in a minority of patients and thus
should not lower the physician’s pre-test probability of
HSVE [27].
Imaging
CNS imaging is an essential step in the diagnostic work-
up and characteristic findings of medial temporal lobe and
insular involvement on neuroimaging studies contribute
significantly to the diagnosis of HSVE. MRI is regarded as
the modality of choice in this setting showing early find-
ings with a high sensitivity. It should be emphasized how-
ever, that atypical or even normal findings may be found
in HSVE, especially in the early stage of the disease [28].
In one series of clinically and biologically diagnosed
HSVE, temporal lobe involvement was present in 60 % of
cases only and up to 25 % of patients had normal studies
(CT or MRI) [29]. The situation seems to be similar in the
postoperative setting where patients have been reported to
have characteristic [20], atypical [22], or even normal [7,
14] presentations. Cerebral MRI can be difficult to inter-
pret after neurosurgery. Postoperative changes and blood
derivatives can mimic infections in diffusion sequences
and enhancement can be observed due to breakdown of
the hematoencephalic barrier. MRI proved to be of signifi-
cant help in the diagnostic procedure of our patient 3
where it showed findings compatible with HSVE. Brain
imaging showed only aspecific findings in the other two
patients, similar to most cases reported previously. Thus,
normal postoperative brain imaging should not prevent
the clinician from considering HSVE in situations where
there is a reasonable clinical suspicion.
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Table 1 Reported Cases of HSVE after Neurosurgery
Author, Year Age Previous
HSVE History
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Bourgeois
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22 No Medullo-bastoma Craniotomy POD >21 HSV Yes None Death
Lellouch
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Cerebrospinal fluid
CSF analysis in sporadic HSVE typically shows a lympho-
cytic pleocytosis with normal glucose and a normal or
mildly-raised protein level, but normal findings can be ob-
served early in the course of the disease [30]. A small num-
ber of erythrocytes are also frequently found in the CSF,
potentially reflecting the hemorrhagic nature of the disease
[31]. Compared to sporadic cases, CSF findings in the post-
operative setting seem not to differ significantly. Lympho-
cytic pleocytosis was the dominant pattern observed in
previous reported cases, but normal findings have also been
described [20]. Our first two cases had only marginal
amount erythrocytes in the CSF, whereas our patient 3
showed a much higher erythrocyte count, potentially pre-
figuring the dramatic forthcoming hemorrhaging trans-
formation. CSF interpretation in the postoperative setting
can be further complicated by the fact that surgery itself
can induce aseptic inflammatory meningitis. Whereas brain
biopsy was previously regarded as the gold standard to
make a definite diagnosis of HSVE, HSV-1/2 PCR on the
CSF is the most efficient test with a sensitivity and specifi-
city of >95 % and >99 %, respectively [32]. Most previously
reported cases were diagnosed by CSF PCR and no further
diagnostic procedure was needed when this examination
was performed. CSF analysis showing a typical lymphocytic
meningitis pattern in all of our 3 cases argued strongly
against a classical bacterial infection. Similar to other re-
ported cases, HSV PCR positivity on the CSF led us to the
diagnosis of HSVE. We consider this method reliable as we
used a fully certified in-house non-commercial PCR assay.
In patient 1, follow-up CSF analyses were ordered in the
setting of a neurosurgical complication. After 14 days of IV
acyclovir treatment, HSV-1 PCR turned negative. However,
it was found to be weakly positive on 2 later occasions (22
and 30 days after treatment onset, respectively). These find-
ings were not correlated with HSVE clinical deterioration
and prompted no specific management. Persistence of PCR
positivity despite appropriate antiviral treatment has been
described and while most patients show CSF PCR negativ-
ity after 1 or 2 weeks of treatment, some can retain PCR
positivity for as long as 35 days [33]. In this setting,
PCR positivity could represent remnant viral DNA.
This finding has not been consistently correlated with
poor outcome [34].
Physiopathology
The postoperative viral pathophysiology of HSVE remains
a subject of debate. HSVE can be caused by a primary
infection by the time of surgery or, more commonly, by a
relapse of previous herpetic infection. A clinical relapse
seems to harbor two distinct entities [35]: The first is
thought to be a post-infectious immune-inflammatory dis-
order without associated viral replication, while the second
involves resumption of active viral replication. This reacti-
vation phenomenon can itself be explained by two distinct
mechanisms [1]: a) reactivation of the virus in the trigemi-
nal ganglion with subsequent retrograde axonal transport
into the CNS; and b) in situ reactivation in the CNS tissue
itself where the virus can be found in a latent form. This
last hypothesis could also account for cases without clinic-
ally overt past HSVE as viral DNA can be detected in the
brain of adults without any neurological disease [36]. In
most previous postoperative cases however, the exact
pathological mechanism is unknown.
Relapse phenomenon is documented in four adults
([15, 16, 25], patient 3) and four pediatric ([5, 7, 8, 10])
cases (Table 2). Among these, only one showed HSV posi-
tivity on brain tissue (autopsy) [16]. In the seven other
cases ([5, 7, 8, 10, 15, 25], patient 3), direct evidence of
cerebral viral presence could not be found or was unavail-
able. As no evidence of in situ latency could be found, re-
activation from an extra-cerebral site probably accounts
for some of these cases. Peripheral reactivation is also the
likely mechanism in one report based on HSV serological
status before and after the clinical event [11]. The same
mechanism is likely in our patient 2 where HSV-2 DNA
PCR was positive on the CSF and standard serological
studies showed a pattern consistent with past infection.
Serum HSV DNA PCR, intrathecal HSV-2 specific IgG
synthesis (Tibbling-Link index), and HSV-1/2 immuno-
staining, as well as PCR on brain biopsy, were all negative.
Globally, these results favor reactivation of the virus in a
sensory ganglion with subsequent retrograde axonal
transport into the brain as no evidence of primary infec-
tion or in situ latency could be found. In our patient 3,
who presented with HSVE relapse, HSV DNA PCR was
Table 3 Clinical Outcome of HSVE after Neurosurgery
Death or sequelae
Overall 14/26 (53.8 %)
Children 4/7 (57.1 %)
Adults 10/19 (52.6 %)
No treatmenta 5/5 (100.0 %)
Treatment 9/21 (42.9 %)
Initiatied≤ 2 daysb 0/5 (0.0 %)
Initiated≥ 3 daysb 8/14 (57.1 %)
aidoxuridine considered as “no treatment”
b2 reports excluded as timing of treatment is not indicated [5, 10]
Table 2 Clinical Characteristics of HSVE after Neurosurgery
Age (mean; range) 32.1; 2-78
Previous HSVE history 8/26 (30.1 %)
Time-to-symptoms in days (mean; range) 7.7; 1-21
HSV-2 etiology 4/26 (15.4 %)
Time to treatment in days (mean; range) 5.8; 0-16
Death or sequelae 14/26 (53.8 %)
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negative on the operative specimen, but positive in CSF
at the time of diagnosis suggesting that peripheral re-
activation started after the surgery. However, the coex-
istence of an immune-inflammatory process is likely
and might explain the unusual diffuse inflammatory
change on MRI and the subsequent malignant edema
that developed under antiviral therapy. Finally, a pure
immune-inflammatory phenomenon without any viral
replication is likely in Lo Presti’s patient as HSV DNA was
not found in CSF or brain tissue [15]. This is supported by
the atypical extensive gray and white matter findings on
MRI. An inability to detect viral presence in brain tissue or
CSF is not uncommon in HSVE sporadic relapse and led
several to speculate an immune-mediated mechanism [37]
whereas autoantibodies directed against NMDA receptors
have been detected in some patients during the course of
an initial episode of HSVE [38]. Armangue et al. recently
studied eight teenagers and adults with HSVE relapse and
showed that 5 had CSF antibodies against NMDA receptors
and three against unknown neuronal cell surface proteins
whereas CSF PCR for HSV was negative in all patients. Ac-
curate characterization of the underlying pathophysiological
mechanism could prove important as prompt immunother-
apy resulted in substantial neurological improvement in
these patients [39].
Classical stimuli triggering HSV reactivation include
fever, local trauma, physical or emotional stress, exposure
to ultraviolet light, hormonal imbalance, and immuno-
suppression [3]. In agreement with previous reports, we
postulate that surgical stress and trauma, as well as cor-
ticosteroid use, may facilitate HSV reactivation in the
postoperative period. Minimal stimulation to the trigemi-
nal sensory root seems to be sufficient to reactivate latent
HSV in humans [40], while dexamethasone has been
shown to induce HSV-1 reactivation in vitro in a dose-
dependent manner [41]. Patients 1 and 2, but not pa-
tient 3, received high-dose dexamethasone after sur-
gery. All previous described cases received steroids,
except for eight cases where steroid use was not docu-
mented [5, 8, 10, 14, 16, 21, 25, 26].
Finally, host factors might play an important role in
HSVE pathophysiology and it has been hypothesized that
late relapses could be related to specific immunological
defects resulting in a particular susceptibility to HSV cere-
bral infection [42]. Mutations in the interferon pathway,
and more specifically in UNC93B1 and TLR3 genes, seem
to confer selective susceptibility to HSV infections [43].
Our patient 3 has been tested for these specific mutations
but results came back negative.
Diagnosis
A diagnosis of encephalitis can be accurately defined using
the International Encephalitis Consortium case definition
[44]. Based on these criteria, our patient 3 meets criteria for
confirmed encephalitis with altered level of consciousness,
fever, abnormal CSF and imaging as well as documented
HSV-1 in CSF. Patients 1 and 2 on the other hand would
only qualify for possible encephalitis as imaging showed no
specific sign of encephalitis. We still think that encephalitis
is more likely than meningitis based on suggestive clinical
findings: Patient 1 presented predominantly with agitated
behavior and decreased level of consciousness requiring
intubation. Moreover, despite rapid improvement under
antiviral treatment, opposing behavior and psychomotor
slowing persisted for a few days. In patient 2, delirium and
temporal disorientation out of proportion with the septic
state pointed towards encephalitis rather than meningitis.
Of note, electroencephalographic data were unfortunately
unavailable for these two patients.
Two elements can explain the atypical imaging in pa-
tients 1 and 2. First, the MRI was realized on the same day
the encephalitic symptoms began possibly accounting for
an early false negative result [28, 29]. Second, a theoretical
possibility exists that these two patients suffered from an
immune-inflammatory predominant form of relapse. As
stated elsewhere [5], findings favoring this hypothesis are
the behavioral dominant clinical picture without focal def-
icit and the atypical neuroimaging results.
Treatment and outcome
Early treatment is of prime importance in HSVE and repre-
sents a major clinical challenge for two reasons. First, the
pathological process in the brain is usually well-advanced
when patients come to clinical attention and, second, initial
signs and symptoms are usually non-specific [30]. Based on
the 26 postoperative reported cases, appropriate antiviral
treatment seems to be a strong predictor of clinical out-
come since death or neurological sequelae were observed
in 100 % of untreated patients as opposed to 43 % in the
treatment group (Table 3). In addition, complete recovery
was universally observed when specific treatment was initi-
ated 2 or fewer days after symptom onset. By contrast,
death or neurological sequelae were reported in 57 % of
cases when the treatment was administered 3 or more days
after symptom onset. This finding is in agreement with the
fact that treatment delay was independently associated with
poor clinical outcome [45]. In patients 1 and 2, acyclovir
treatment was started less than 3 days after symptom onset,
thus allowing complete recovery. In patient 3, antiviral
treatment was initiated at day 4 after symptom onset,
possibly accounting for the mild neurological sequelae. Our
three patients have been treated with 21 days of IV acyclo-
vir: 10 mg/kg two times daily, 15 mg/kg two times daily,
and 20 mg/kg two times daily (patients 1, 2 and 3, respect-
ively). Given the rarity of postoperative HSVE, no estab-
lished guidelines exist regarding treatment. For HSV-1
sporadic cases, the Infectious Diseases Society of America
2008 guidelines recommend 10 mg/kg two times daily for
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14–21 days in the adult population (20 mg/kg in neonates).
Some experts advocate a slightly higher dosage of 15 mg/kg
two times daily. Of note, although presenting with en-
cephalitis, patient 2 suffered from HSV-2 infection. As
reported recently [27], there is no standard approach to
the treatment of sporadic HSV-2 CNS infection. For
HSV-2 meningitis, expert opinion usually recommends
IV acyclovir 10 mg/kg two times daily for 10–14 days with
a possible per os switch, but some argue that no treatment
is needed for a first and uncomplicated episode. No guide-
lines exist regarding HSV-2 encephalitis treatment. Since
HSV-2 encephalitis can induce neurological sequelae in a
significant percentage of cases [2], we recommend to treat
these patients as if they had HSV-1 encephalitis.
Conclusions
Although the vast majority of infectious complications
of neurosurgical procedures are of bacterial origin, post-
operative HSVE is an established entity. Although HSV-
1 is usually the causative agent, HSV-2 can also cause
an encephalitic pattern. Given the severity of the disease
and the prognostic implication of treatment delay,
prompt initiation of IV acyclovir is of prime importance.
Thus, we recommend empirical acyclovir treatment in
the appropriate clinical setting whenever CSF analysis is
consistent with viral meningo-encephalitis. CSF viral-
specific PCR together with MRI brain imaging are diag-
nostic modalities of choice. In agreement with other
experts [5, 11, 15, 16], we recommend prophylactic anti-
viral treatment for patients with an HSVE previous
history undergoing neurosurgery. Considering that post-
operative HSVE is rare, potentially overlooked and
always severe, randomized controlled studies are im-
probable and clinicians should adapt their clinical prac-
tice based on these data.
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